Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing PlatformPRNewsWire • 03/04/26
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11GlobeNewsWire • 02/25/26
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide TherapeuticsPRNewsWire • 01/07/26
Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS)Zacks Investment Research • 11/11/25
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA ManufacturingPRNewsWire • 10/29/25
Codexis' Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNAGlobeNewsWire • 05/22/25
Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual MeetingGlobeNewsWire • 05/07/25
Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 04/24/25